Practice Expertise
- Corporate & Commercial
- Mergers & Acquisitions
- Industry & Commerce
- Healthcare & Life Sciences
Areas of Practice
- Corporate & Commercial
- Healthcare & Life Sciences
- Industry & Commerce
- Mergers & Acquisitions
- Corporate / M&A View More
Profile
Simon Olstein works as an associate at Walder Wyss. He advises clients predominantly in the areas of healthcare & life sciences, with a particular focus on contract and corporate law, M&A transactions as well as venture capital and financing.
Born in 1993, Simon Olstein studied law at the University of Basel (MLaw 2018) and at Tel Aviv University and passed the bar exam in the Canton of Basel-Stadt in 2021. Prior to joining Walder Wyss, he gained professional experience at the Civil Court of Basel-Stadt and at a renowned commercial law firm in Zurich, among others. In addition, Simon Olstein worked in the legal department of a leading global life science company at the divisional headquarters in Basel and served most recently as a Legal Counsel for an international specialty pharmaceutical company.
Simon Olstein primarily advises clients in German and English and speaks French as well. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.
Born in 1993, Simon Olstein studied law at the University of Basel (MLaw 2018) and at Tel Aviv University and passed the bar exam in the Canton of Basel-Stadt in 2021. Prior to joining Walder Wyss, he gained professional experience at the Civil Court of Basel-Stadt and at a renowned commercial law firm in Zurich, among others. In addition, Simon Olstein worked in the legal department of a leading global life science company at the divisional headquarters in Basel and served most recently as a Legal Counsel for an international specialty pharmaceutical company.
Simon Olstein primarily advises clients in German and English and speaks French as well. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.
Areas of Practice
- Corporate & Commercial
- Healthcare & Life Sciences
- Industry & Commerce
- Mergers & Acquisitions
- Corporate / M&A
Professional Career
Significant Accomplishments
SixPeaks Bio AG debuts with USD 110 million in Funding
Axalta Coating Systems Group acquires André Koch AG
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round
CONVOTIS stärkt seine Position in der Schweiz durch die neueste Akquisition der acdalis AG, einem anerkannten Spezialisten für Managed Cloud und Infrastruktur Services.
Zusammenschluss von SETEX und Datatex mit Elvaston
CONVOTIS startet mit der Übernahme der JMC Gruppe als Plattformunternehmen in den Schweizer IT Markt und stärkt seine Positionierung im Segment der Managed Services und digitalen Plattformlösungen.
LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
Pierre Fabre Laboratories acquires Vertical Bio AG
Das Familienunternehmen Henke-Sass, Wolf GmbH übernimmt die Zünd Präzisionsoptik AG
Skribble AG completes Series A round of funding
groupe.id joins Elvaston
Elvaston sells Magnolia International AG to GENUI
SixPeaks Bio AG debuts with USD 110 million in Funding
Axalta Coating Systems Group acquires André Koch AG
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round
CONVOTIS stärkt seine Position in der Schweiz durch die neueste Akquisition der acdalis AG, einem anerkannten Spezialisten für Managed Cloud und Infrastruktur Services.
Zusammenschluss von SETEX und Datatex mit Elvaston
CONVOTIS startet mit der Übernahme der JMC Gruppe als Plattformunternehmen in den Schweizer IT Markt und stärkt seine Positionierung im Segment der Managed Services und digitalen Plattformlösungen.
LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
Pierre Fabre Laboratories acquires Vertical Bio AG
Das Familienunternehmen Henke-Sass, Wolf GmbH übernimmt die Zünd Präzisionsoptik AG
Skribble AG completes Series A round of funding
groupe.id joins Elvaston
Elvaston sells Magnolia International AG to GENUI
Articles
Beschaffungsmöglichkeiten für Medizinprodukte im Lichte einer drohenden Versorgungslücke in der Schweiz
Meet our Firms and Professionals
WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.
